Phase III Study of Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis: ORATORIO Study Design

被引：0
|
作者：
Montalban, Xavier
Wolinsky, Jerry
Yin, Ming
Leppert, David
Glanzman, Robert
Chin, Peter
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A319 / A320
页数：2
相关论文
共 50 条
  • [1] Prespecified subgroup analyses of ocrelizumab efficacy in patients with primary progressive Multiple Sclerosis from the Phase III ORATORIO Study
    Kappos, L.
    Montalban, X.
    Hauser, S. L.
    Julian, L.
    Manfrini, M.
    Belachew, S.
    Model, F.
    Hubeaux, S.
    Bar-or, A.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 431 - 431
  • [2] Effect of ocrelizumab on upper limb function in patients with primary progressive multiple sclerosis in the ORATORIO study
    Fox, E. J.
    Markowitz, C.
    Applebee, A.
    Montalban, X.
    Wolinsky, J. S.
    Belachew, S.
    Fiore, D.
    Han, J.
    Musch, B.
    Giovannoni, G.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 658 - 659
  • [3] OCRELIZUMAB IN PRIMARY PROGRESSIVE MS: THE ORATORIO STUDY
    Giovannoni, G.
    Arnold, D. L.
    Bar-Or, A.
    de Seze, J.
    Hemmer, B.
    Montalban, X.
    Rammohan, K.
    Wolinsky, J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):
  • [4] Baseline Demographics and Disease Characteristics from ORATORIO, a Phase III Trial Evaluating Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis
    Montalban, X.
    Hemmer, B.
    Rammohan, K.
    Giovannoni, G.
    de Seze, J.
    Bar-Or, A.
    Arnold, D.
    Sauter, A.
    Leppert, D.
    Chin, P.
    Garren, H.
    Messier, M.
    Wolinski, J.
    Kakarieka, A.
    Masterman, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 706 - 706
  • [5] EFFECT OF OCRELIZUMAB ON UPPER LIMB FUNCTION IN PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (PPMS) IN THE ORATORIO STUDY (ENCORE)
    Fox, Edward
    Markowitz, Clyde
    Applebee, Angela
    Montalban, Xavier
    Wolinsky, Jerry S.
    Belachew, Shebeshih
    Fiore, Damian
    Han, Jian
    Musch, Bruno
    Giovannoni, Gavin
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E14 - E14
  • [6] Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis - results of the placebo-controlled, double-blind, Phase III ORATORIO study
    Montalban, X.
    Hemmer, B.
    Rammohan, K.
    Giovannoni, G.
    de Seze, J.
    Bar-Or, A.
    Arnold, D. L.
    Sauter, A.
    Kakarieka, A.
    Masterman, D.
    Chin, P.
    Garren, H.
    Wolinsky, J.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 781 - 782
  • [7] Efficacy and Safety of Ocrelizumab in Primary Progressive Multiple Sclerosis: Results of the Phase III Double-Blind, Placebo-Controlled ORATORIO Study
    Montalban, Xavier
    Hemmer, Bernhard
    Rammohan, Kottil
    Giovannoni, Gavin
    De Seze, Jerome
    Bar-Or, Amit
    Arnold, Douglas
    Sauter, Annette
    Masterman, Donna
    Fontoura, Paulo
    Garren, Hideki
    Chin, Peter
    Wolinsky, Jerry
    NEUROLOGY, 2016, 86
  • [8] Patient-reported outcomes in the phase III double-blind, placebo-controlled ORATORIO study of ocrelizumab in primary progressive multiple sclerosis
    de Seze, J.
    Montalban, X.
    McDougall, F.
    Sauter, A.
    Deol-Bhullar, G.
    Wolinsky, J.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 677 - 678
  • [9] Patient-reported outcomes in the phase III double-blind, placebo-controlled ORATORIO study of ocrelizumab in primary progressive multiple sclerosis
    de Seze, Jerome
    Montalban, Xavier
    McDougall, Fiona
    Julian, Laura
    Sauter, Annette
    Deol-Bhullar, Gurpreet
    Wolinsky, Jerry
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 84 - 84
  • [10] Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial
    Fox, Edward J.
    Markowitz, Clyde
    Applebee, Angela
    Montalban, Xavier
    Wolinsky, Jerry S.
    Belachew, Sihbeshih
    Fiore, Damian
    Pei, Jinglan
    Musch, Bruno
    Giovannoni, Gavin
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (14) : 1862 - 1870
12345